Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-08-08Clinical Trial Update: Study of Lenalidomide and Ofatumumab for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating lenalidomide plus ofatumumab for relapsed or refractory non-Hodgkin's lymphoma was completed with res…
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: Bortezomib and Vorinostat in Treating Patients With Recurrent Mantle Cell Lymphoma or Recurrent and/or Refractory Diffuse Large B-Cell Lymphoma [Phase 2]
Phase 2 trial of bortezomib plus vorinostat in recurrent mantle cell lymphoma or recurrent/diffuse large B-cell lymphoma has completed with …
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies [NA]
Clinical trial update evaluating the feasibility of the iThermonitor in pediatric patients receiving myelosuppressive therapies; the study i…
-
CLINICAL_TRIALS research · 2018-07-26Clinical Trial Update: Chidamide Combined With Clad/Gem/Bu With AutoSCT in High Risk Hodgkin & Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial conducted by Sichuan University is evaluating a combination of chidamide with cladribine, gemcitabine, and busulfan…
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating VELCADE (bortezomib) with BEAM conditioning and autologous stem cell transplantation in non-Hodgkin's lymphoma an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-07-24Clinical Trial Update: Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab [Phase 2]
Phase 2 trial update on optimized donor selection with nonmyeloablative bone marrow transplant using post-transplant cyclophosphamide and ri…
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy
This completed prospective observational study evaluated febrile neutropenia and pegfilgrastim primary prophylaxis in breast cancer and Non-…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors [Phase 1]
This clinical trial update reports the completion of a Phase 1 study of CB-839 (telaglenastat), a glutaminase inhibitor, in hematological tu…
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: Assessment of Safety and Efficacy of IM19 for Relapsed or Refractory NHL Patients [Phase 1]
A Phase 1 trial evaluating the safety and preliminary efficacy of IM19 in relapsed or refractory non-Hodgkin lymphoma patients.
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs) [Phase 2]
A Phase 2 trial evaluating eltrombopag for immune thrombocytopenia occurring in patients with chronic lymphoproliferative disorders has comp…
-
CLINICAL_TRIALS trial_result · 2018-07-13Clinical Trial Update: Ibritumomab Tiuxetan (Zevalin)+ Rituximab Maintenance [Phase 2]
Phase 2 trial of ibritumomab tiuxetan (Zevalin) with rituximab maintenance in non-Hodgkin's lymphoma was terminated; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-07-09Clinical Trial Update: Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides [Phase 3]
Phase 3 study evaluating ultraviolet light therapy using methoxsalen with or without bexarotene for mycosis fungoides; the trial was termina…
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: IMPACT Non Hodgkins Lymphoma (NHL) Study
Amgen's IMPACT trial in non-Hodgkin's lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants [Phase 1]
Phase 1 clinical trial evaluating donor T-helper 2 (Th2) cell therapy to prevent graft-versus-host disease after bone marrow transplantation…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: MabRella Study: A Study to Evaluate the Safety of Switching From Intravenous to Subcutaneous Administration of Rituximab During First-Line Treatment for Lymphoma [Phase 3]
A Phase 3 trial evaluating safety of switching from intravenous to subcutaneous rituximab during first-line treatment for lymphoma shows com…
-
CLINICAL_TRIALS research · 2018-07-02Clinical Trial Update: Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer [NA]
Clinical trial update on caregiver-delivered massage therapy to improve quality of life in pediatric cancer patients; the study (NCT01053494…
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating combination chemotherapy with pralatrexate as first-line therapy for non-Hodgkin lymphomas, including various T-cel…
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Music & Cancer - Live Music During Chemotherapy [NA]
This clinical trial update reports the completion of a study evaluating live music during chemotherapy for patients with non-Hodgkin lymphom…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
The National Cancer Institute-sponsored clinical trial assessing relapse in malignant blood cancers after allogeneic hematopoietic stem cell…
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma [Phase 1]
Phase 1 clinical trial update on AR-42 in adults with advanced or relapsed multiple myeloma, chronic lymphocytic leukemia, and various lymph…
-
CLINICAL_TRIALS research · 2018-05-30Clinical Trial Update: Cytoplasmic Activated PD-1 CAR T Cells in Refractory/Relapsed B Cell Lymphoma [Phase 1]
Phase 1 clinical trial update on Cytoplasmic Activated PD-1 CAR T Cells for relapsed/refractory B-cell non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2018-05-29Clinical Trial Update: Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies [Phase 1]
Phase I trial update of milatuzumab (anti-CD74/hLL1) antibody therapy in B cell malignancies, including non-Hodgkin lymphoma and chronic lym…
-
CLINICAL_TRIALS trial_result · 2018-05-24Clinical Trial Update: Safety and Efficacy Evaluation of Decitabine With R-GDP [Phase 1]
Phase 1 study evaluating the safety and preliminary efficacy of decitabine in combination with the R-GDP regimen for non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating panobinostat with everolimus in recurrent hematologic malignancies including multiple myeloma and non-Hodgkin lym…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial of panobinostat in relapsed or refractory non-Hodgkin lymphoma completed; results posted in 2018.